Follow the TRANSGENOMIC INC stock price and the full management transaction log of the company, a publicly traded company based in United States. Shares trade on US US, under the supervision of SEC (Form 4). The latest transaction was reported on 11 January 2016 (C). Among the most active insiders: KIRK RANDAL J. All data is accessible without an account.
8
Insider Decl.
0
Thresholds
·
4 ops.
Buy Volume
·
0 ops.
Sell Volume
2Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Transgenomic Inc is a company specializing in genomic and molecular biology technologies. It develops solutions for the diagnosis and treatment of genetic diseases.